Concepedia

Publication | Open Access

Primary PFS and safety analyses of a randomized phase III study of carboplatin + paclitaxel +/− bevacizumab, with or without atezolizumab in 1L non-squamous metastatic nsclc (IMPOWER150)

DOIFull Paper Access

44

Citations

0

References

2017

Year

Martin Reck, Mark A. Socinski, Federico Cappuzzo, Francesco Orlandi, Daniil Stroyakovskii, Naoyuki Nogami, Delvys Rodríguez‐Abreu, Denis Moro‐Sibilot, C.A. Thomas, Fabrice Barlési,
Annals of Oncology

No additional data available for this publication yet. Check back later!